By contrast, evidence from FGFR2-fusion intrahepatic cholangiocarcinoma is limited and sometimes inconsistent, underscoring the need for tumor-specific interpretation of FGFR–interferon crosstalk [140,141]. The gene discussed is FGFR2; the disease is neoplasm.